| 标题 |
LB0004 EFFICACY AND SAFETY OF DEUCRAVACITINIB, AN ORAL, SELECTIVE, ALLOSTERIC TYK2 INHIBITOR, IN PATIENTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS: A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of the Rheumatic Diseases 作者:E. Morand; M. Pike; J.T. Merrill; R. Van Vollenhoven; V.P. Werth; et al 出版日期:2022 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)